Oncolytic and Local Immunotherapy

A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
Feng-Ying Huang, Jin-Yan Wang, Shu-Zhen Dai, Ying-Ying Lin, Yan Sun, Liming Zhang, Zhuoxuan Lu, Rong Cao, Guang-Hong Tan

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000330; DOI: 10.1136/jitc-2019-000330
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Eva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, Shane Foo, Emmanuel C Patin, Harriet Whittock, Richard Buus, Syed Haider, Gareth Muirhead, Khin Thway, Kate Newbold, Robert S Coffin, Richard G Vile, Dae Kim, Martin McLaughlin, Alan A Melcher, Kevin J Harrington, Malin Pedersen

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000698; DOI: 10.1136/jitc-2020-000698
Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade
Bo-Kyeong Jung, Hae Young Ko, Hyunji Kang, JinWoo Hong, Hyo Min Ahn, Youjin Na, Hyeongi Kim, Jin Su Kim, Chae-Ok Yun

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000763; DOI: 10.1136/jitc-2020-000763
A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
María Alejandra Gleisner, Cristián Pereda, Andrés Tittarelli, Mariela Navarrete, Camila Fuentes, Ignacio Ávalos, Fabian Tempio, Juan Pablo Araya, María Inés Becker, Fermín Eduardo González, Mercedes Natalia López, Flavio Salazar-Onfray

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000999; DOI: 10.1136/jitc-2020-000999
Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
Erica B Flores, Bulent A Aksoy, Eric Bartee

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000804; DOI: 10.1136/jitc-2020-000804
Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies
Lambros Tselikas, Thierry de Baere, Thomas Isoardo, Sandrine Susini, Karine Ser-Le Roux, Mélanie Polrot, Julien Adam, Mathieu Rouanne, Laurence Zitvogel, Laurence Moine, Fréderic Deschamps, Aurélien Marabelle

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000579; DOI: 10.1136/jitc-2020-000579
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
Dipongkor Saha, Samuel D Rabkin, Robert L Martuza

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000345; DOI: 10.1136/jitc-2019-000345
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
Marisa O Peluso, Ammar Adam, Caroline M Armet, Li Zhang, Rachel W O’Connor, Benjamin H Lee, Andrew C Lake, Emmanuel Normant, Scott C Chappel, Jonathan A Hill, Vito J Palombella, Pamela M Holland, Alison M Paterson

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000413; DOI: 10.1136/jitc-2019-000413
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
Yan Ge, Haiyan Wang, Jinghua Ren, Weilin Liu, Lingjuan Chen, Hongqi Chen, Junjie Ye, Enyong Dai, Congrong Ma, Songguang Ju, Zong Sheng Guo, Zuqiang Liu, David L Bartlett

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000710; DOI: 10.1136/jitc-2020-000710
Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8⁺ T-cell functionality
Seyedeh-Raheleh Niavarani, Christine Lawson, Marie Boudaud, Camille Simard, Lee-Hwa Tai

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000465; DOI: 10.1136/jitc-2019-000465

Main menu

Oncolytic and Local Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Oncolytic and Local Immunotherapy

Pages